arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

MIMEDX GROUP, INC.

MDXG
$3.27 ▲ +0.06 (+1.87%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
16 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
81
Health
Excellent
Bullish
auto_awesome

Analytical Summary

MIMEDX GROUP, INC. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $483.3M
Dividend Yield —
Revenue Growth 20.0% ↗
Op. Margin 15.3% ↘
ROIC 17.1% ↘
FCF / Share $0.50 ↗
Trailing P/E 9.9x
Price / Book 1.9x
FCF Yield 15.3%
Debt / Equity 0.07
info Valuation on last close. End-of-day price, Nov 5, 2026.

16-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$418.63M
↑ +20.0% —
Net Income Profit after all expenses
$48.58M
↑ +14.5% —
Operating Margin Operating profit as % of sales
15.3%
↓ -9.6% 67th
FCF / Share Free cash flow per share
$0.50
↑ +11.2% —
Long-Term Debt Long-term obligations
$18.00M
↑ +1.0% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
71
Returns
85
Financial Health ↓
89
Cash Quality ↑
80

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 16 years · 64 quarters